AVTX stockholders approve reverse stock split with ratio up to 1:250

Avalo Therapeutics, Inc.

Reverse stock split approved: 34.7M for, 31.6M against, 0.8M abstain (54.8% of votes cast).
Board will determine final ratio between 1:5 and 1:250; split intended to maintain Nasdaq listing.
Annual meeting quorum was 34.88% (67.1M of 192.4M shares outstanding).
All five director nominees elected; Ernst & Young ratified as auditor for FY2023.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Avalo Therapeutics, Inc. shareholders approved Approval of an Amendment to our Certificate of Incorporation to Effect a Reverse Stock Split at the 2023-12-20 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2023-12-20

Exact text from the filing

Proposal 2: Approval of an Amendment to our Certificate of Incorporation to Effect a Reverse Stock Split

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Avalo Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-12-20 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-12-20

Exact text from the filing

Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Avalo Therapeutics, Inc. shareholders approved Election of Directors at the 2023-12-20 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-12-20

Exact text from the filing

Proposal 1: Election of Directors By the vote reflected below, the Company’s stockholders elected each of the following individuals to the Board to hold office until the 2024 Annual Meeting and until their respective successors are elected and qualified.

View on SEC.gov

1179 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Avalo Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-042223

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.